We are live on
!
Find out more
OCM
Orleans Capital Management Portfolio holdings
AUM
$148M
1-Year Est. Return
24.31%
This Fund
S&P 500
This Quarter
Est. Return
+8.65%
1 Year Est. Return
+24.31%
3 Year Est. Return
+67.86%
5 Year Est. Return
+100.75%
10 Year Est. Return
+214.87%
AUM
$152M
AUM Growth
+$3.42M
(+2.3%)
Cap. Flow
-$7.78M
Cap. Flow
% of AUM
-5.11%
Top 10 Holdings %
Top 10 Hldgs %
38.64%
Holding
86
New
5
Increased
26
Reduced
35
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.31M |
| 2 |
Stryker
SYK
|
+$1.06M |
| 3 |
Mastercard
MA
|
+$974K |
| 4 |
Amazon
AMZN
|
+$936K |
| 5 |
MetLife
MET
|
+$626K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.58M |
| 2 |
Microsoft
MSFT
|
+$1.45M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$966K |
| 4 |
ConocoPhillips
COP
|
+$827K |
| 5 |
Chevron
CVX
|
+$822K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.35% |
| 2 | Healthcare | 10.76% |
| 3 | Financials | 10.73% |
| 4 | Industrials | 8.28% |
| 5 | Energy | 7.15% |
Similar funds
CWMS
MM
JWM
AWA
NLA
WC
SFP
GCA
Orleans Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Orleans Capital Management held 86 positions worth $152M, up 2.3% from $149M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Orleans Capital Management withdrew a net $7.78M in Q1 2024, closing 11 positions and reducing 35 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $755K position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Orleans Capital Management opened a new position in Linde worth $1.4M.
- Orleans Capital Management's largest Q1 2024 buy was Linde: 3,020 shares worth $1.4M.
- Orleans Capital Management added most to Stryker in Q1 2024, an estimated $1.06M increase.
- Orleans Capital Management's biggest Q1 2024 reduction was Apple, cutting an estimated $1.58M.
- Orleans Capital Management fully exited Bristol-Myers Squibb in Q1 2024, selling an estimated $755K.
- Orleans Capital Management's ten largest holdings make up 39% of its $152M portfolio in Q1 2024.
- Orleans Capital Management opened 5 new positions and closed 11 in Q1 2024.
- Orleans Capital Management's portfolio value rose 2.3% quarter-over-quarter to $152M.
Based on Orleans Capital Management's 13F filing for Q1 2024, filed 22 May 2024.